Hugel is entering the Thai hyaluronic acid (HA) filler market.


On the 16th, a commemorative meeting for the launch of Hugel's hyaluronic acid (HA) filler in the Thai market was held at the Eastin Grand Hotel Phayathai in Bangkok, Thailand. <br>[Photo by Hugel]

On the 16th, a commemorative meeting for the launch of Hugel's hyaluronic acid (HA) filler in the Thai market was held at the Eastin Grand Hotel Phayathai in Bangkok, Thailand.
[Photo by Hugel]

View original image

Hugel announced on the 29th that it recently launched the HA filler 'Revolax' (domestic name The Chaeum), which received product approval from the Thai Food and Drug Administration (TFDA) in August last year. This marks the first case of a Korean company entering all three markets in Thailand: HA fillers, botulinum toxin, and polydioxanone (PDO) sutures.


To commemorate the brand launch, Hugel held a seminar on the 16th at the Eastin Grand Hotel Phayathai in Bangkok, Thailand, attended by over 250 local medical professionals. The event, themed "Filling Like New You," featured speakers from both overseas and local authorities who shared the latest insights tailored to the region.


Dr. Bejan Sultani, a plastic surgeon from Germany's Mori Clinics, explained the product's features and safety based on extensive clinical experience. Following him, Professor Tanba Tansapit from the Faculty of Medicine at Siam University and Dr. Batchapon Tanamitramani, a dermatologist at Doctor Mek Clinic in Thailand, introduced the current status of the Thai filler market and the overall product.


Prior to the seminar, Dr. Sultani also conducted a small-scale 'hands-on training' for beginners in procedures. Participants expressed high satisfaction, saying, "It was a professional education where we could directly experience the formulation and injection feel and learn procedural techniques."



A Hugel representative stated, "Since Hugel's botulinum toxin holds the number one market share in Thailand, the HA filler is also receiving significant attention from local medical professionals. We will continue to communicate with key opinion leaders (KOLs) to successfully establish the product and further strengthen our market share."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing